{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:19:29Z","timestamp":1791994769139,"version":"4.4.0"},"reference-count":36,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,10,15]]},"abstract":"<jats:p>Reduced levels of p27Kip1 are frequent in human cancers and have been associated with poor prognosis. Skp2, a component of the Skp1-Cul1-F-box protein (SCF) ubiquitin ligase complex, has been implicated in p27Kip1 degradation. Increased Skp2 levels are seen in some solid tumors and are associated with reduced p27Kip1. We examined the expression of these proteins using single and double immunolabeling in a large series of lymphomas to determine if alterations in their relative levels are associated with changes in cell proliferation and lymphoma subgroups. We studied the expression of Skp2 in low-grade and aggressive B-cell lymphomas (n\u2009=\u200986) and compared them with p27Kip1 and the proliferation index (PI). Fifteen hematopoietic cell lines and peripheral blood lymphocytes were studied by Western blot analysis. In reactive tonsils, Skp2 expression was limited to proliferating germinal center and interfollicular cells. Skp2 expression in small lymphocytic lymphomas (SLLs) and follicular lymphomas (FCLs) was low (mean percentage of positive tumor cells, less than 20%) and was inversely correlated (r\u2009=\u2009\u22120.67;P\u2009&lt;\u2009.0001) with p27Kip1 and positively correlated with the PI (r\u2009=\u20090.82;P\u2009&lt;\u2009.005). By contrast, whereas most mantle cell lymphomas (MCLs) demonstrated low expression of p27Kip1 and Skp2, a subset (n\u2009=\u20096) expressed high Skp2 (exceeding 20%) with a high PI (exceeding 50%). Skp2 expression was highest in diffuse large B-cell lymphomas (DLBCLs) (mean, 22%) and correlated with Ki-67 (r\u2009=\u20090.55;P\u2009&lt;\u2009.005) but not with p27Kip1. Cytoplasmic Skp2 was seen in a subset of aggressive lymphomas. Our data provide evidence for p27Kip1 degradative function of Skp2 in low-grade lymphomas. The absence of this relationship in aggressive lymphomas suggests that other factors contribute to deregulation of p27Kip1 expression in these tumors.<\/jats:p>","DOI":"10.1182\/blood.v100.8.2950","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T23:44:31Z","timestamp":1033083871000},"page":"2950-2956","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":111,"title":["Expression of Skp2, a p27Kip1 ubiquitin ligase, in malignant lymphoma: correlation with p27Kip1 and proliferation index"],"prefix":"10.1182","volume":"100","author":[{"given":"Megan S.","family":"Lim","sequence":"first","affiliation":[{"name":"From the Department of Pathology and ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City; the Department of Anatomic Pathology, Sunnybrook Women's College Health Sciences Centre, University of Toronto, ON, Canada; and the Department of Oral Pathology, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Adamson","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City; the Department of Anatomic Pathology, Sunnybrook Women's College Health Sciences Centre, University of Toronto, ON, Canada; and the Department of Oral Pathology, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaosheng","family":"Lin","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City; the Department of Anatomic Pathology, Sunnybrook Women's College Health Sciences Centre, University of Toronto, ON, Canada; and the Department of Oral Pathology, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayardo","family":"Perez-Ordonez","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City; the Department of Anatomic Pathology, Sunnybrook Women's College Health Sciences Centre, University of Toronto, ON, Canada; and the Department of Oral Pathology, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C. K.","family":"Jordan","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City; the Department of Anatomic Pathology, Sunnybrook Women's College Health Sciences Centre, University of Toronto, ON, Canada; and the Department of Oral Pathology, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Tripp","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City; the Department of Anatomic Pathology, Sunnybrook Women's College Health Sciences Centre, University of Toronto, ON, Canada; and the Department of Oral Pathology, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrie L.","family":"Perkins","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City; the Department of Anatomic Pathology, Sunnybrook Women's College Health Sciences Centre, University of Toronto, ON, Canada; and the Department of Oral Pathology, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojo S. J.","family":"Elenitoba-Johnson","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City; the Department of Anatomic Pathology, Sunnybrook Women's College Health Sciences Centre, University of Toronto, ON, Canada; and the Department of Oral Pathology, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111822051481900_B1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nm0297-227","article-title":"Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.","volume":"3","author":"Catzavelos","year":"1997","journal-title":"Nat Med."},{"key":"2019111822051481900_B2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1098-2744(199911)26:3<172::AID-MC6>3.0.CO;2-8","article-title":"Reduced expression and altered subcellular localization of the cylin-dependent kinase inhibitor p27(Kip1) in human colon cancer.","volume":"26","author":"Sgambato","year":"1999","journal-title":"Mol Carcinog."},{"key":"2019111822051481900_B3","first-page":"1730","article-title":"Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.","volume":"58","author":"Singh","year":"1998","journal-title":"Cancer Res."},{"key":"2019111822051481900_B4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I","article-title":"Regulation of the Cdk inhibitor p27 and its deregulation in cancer.","volume":"183","author":"Slingerland","year":"2000","journal-title":"J Cell Physiol."},{"key":"2019111822051481900_B5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9440(10)65610-6","article-title":"Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases.","volume":"153","author":"Thomas","year":"1998","journal-title":"Am J Pathol."},{"key":"2019111822051481900_B6","first-page":"3381","article-title":"Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.","volume":"57","author":"Esposito","year":"1997","journal-title":"Cancer Res."},{"key":"2019111822051481900_B7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V92.3.770","article-title":"Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas: prognostic implications.","volume":"92","author":"Erlanson","year":"1998","journal-title":"Blood."},{"key":"2019111822051481900_B8","first-page":"542","article-title":"Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.","volume":"58","author":"Tsihlias","year":"1998","journal-title":"Cancer Res."},{"key":"2019111822051481900_B9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4615-1809-9_11","article-title":"p27KIP1, an inhibitor of cyclin-dependent kinases.","volume":"1","author":"Koff","year":"1995","journal-title":"Prog Cell Cycle Res."},{"key":"2019111822051481900_B10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/bbrc.1997.7590","article-title":"Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E\/Cdk2.","volume":"240","author":"Morisaki","year":"1997","journal-title":"Biochem Biophys Res Commun."},{"key":"2019111822051481900_B11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9440(10)65558-7","article-title":"Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.","volume":"153","author":"Quintanilla-Martinez","year":"1998","journal-title":"Am J Pathol."},{"key":"2019111822051481900_B12","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.271.5257.1861","article-title":"Translational control of p27Kip1 accumulation during the cell cycle.","volume":"271","author":"Hengst","year":"1996","journal-title":"Science."},{"key":"2019111822051481900_B13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1182\/blood.V94.2.765","article-title":"Anomalous high p27\/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression: p27\/KIP1-cyclin D3 colocalization in tumor cells.","volume":"94","author":"Sanchez-Beato","year":"1999","journal-title":"Blood."},{"key":"2019111822051481900_B14","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1038\/sj.onc.1203162","article-title":"Antiproliferative function of p27Kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.","volume":"18","author":"Barnouin","year":"1999","journal-title":"Oncogene."},{"key":"2019111822051481900_B15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.leu.2400581","article-title":"Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation.","volume":"11","author":"Allessandrini","year":"1997","journal-title":"Leukemia."},{"key":"2019111822051481900_B16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0960-9822(99)80290-5","article-title":"p27 (Kip1) ubitquitin and degradation is regulated by the SCF (Skp2) complex through phosphorylated Thr187 in p27.","volume":"9","author":"Tsvetkov","year":"1999","journal-title":"Curr Biol."},{"key":"2019111822051481900_B17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-5793(99)00629-8","article-title":"Skp2 induction and phosphorylation is associated with the late G1 phase of proliferating rat hepatocytes.","volume":"452","author":"Bilodeau","year":"1999","journal-title":"FEBS Lett."},{"key":"2019111822051481900_B18","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/emboj\/19.9.2069","article-title":"Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.","volume":"19","author":"Nakayama","year":"2000","journal-title":"EMBO J."},{"key":"2019111822051481900_B19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1006\/bbrc.2001.4442","article-title":"The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.","volume":"281","author":"Yeh","year":"2001","journal-title":"Biochem Biophys Res Commun."},{"key":"2019111822051481900_B20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(95)90271-6","article-title":"p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase.","volume":"82","author":"Zhang","year":"1995","journal-title":"Cell."},{"key":"2019111822051481900_B21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/bbrc.2001.4627","article-title":"Regulation of the cell cycle at the G(1)-S transition by proteolysis of cyclin E and p27(Kip1).","volume":"282","author":"Nakayama","year":"2001","journal-title":"Biochem Biophys Res Commun."},{"key":"2019111822051481900_B22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/8984","article-title":"Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation.","volume":"1","author":"Marti","year":"1999","journal-title":"Nat Cell Biol."},{"key":"2019111822051481900_B23","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1073\/pnas.081474898","article-title":"Skp2 is oncogenic and overexpressed in human cancers.","volume":"98","author":"Gstaiger","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111822051481900_B24","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1073\/pnas.041475098","article-title":"Role of the F-box protein Skp2 in lymphomagenesis.","volume":"98","author":"Latres","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111822051481900_B25","first-page":"361","article-title":"Classification of malignant lymphoma. WHO international proposal [in French].","volume":"18","author":"Diebold","year":"1998","journal-title":"Ann Pathol."},{"key":"2019111822051481900_B26","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1093\/emboj\/16.17.5334","article-title":"Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.","volume":"16","author":"Vlach","year":"1997","journal-title":"EMBO J."},{"key":"2019111822051481900_B27","doi-asserted-by":"crossref","first-page":"13886","DOI":"10.1074\/jbc.274.20.13886","article-title":"Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing.","volume":"274","author":"Shirane","year":"1999","journal-title":"J Biol Chem."},{"key":"2019111822051481900_B28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0959-437X(97)80103-7","article-title":"Phosphorylation and proteolysis: partners in the regulation of cell division in budding yeast.","volume":"7","author":"Deshaies","year":"1997","journal-title":"Curr Opin Genet Dev."},{"key":"2019111822051481900_B29","doi-asserted-by":"crossref","first-page":"REVIEWS3002","DOI":"10.1186\/gb-2000-1-5-reviews3002","article-title":"The F-box protein family.","volume":"1","author":"Kipreos","year":"2000","journal-title":"Genome Biol."},{"key":"2019111822051481900_B30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/12027","article-title":"p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells.","volume":"1","author":"Sutterluty","year":"1999","journal-title":"Nat Cell Biol."},{"key":"2019111822051481900_B31","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1038\/sj.onc.1204501","article-title":"A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT.","volume":"20","author":"Ganiatsas","year":"2001","journal-title":"Oncogene."},{"key":"2019111822051481900_B32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/12013","article-title":"SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.","volume":"1","author":"Carrano","year":"1999","journal-title":"Nat Cell Biol."},{"key":"2019111822051481900_B33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V95.2.619","article-title":"Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.","volume":"95","author":"Chiarle","year":"2000","journal-title":"Blood."},{"key":"2019111822051481900_B34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/jcb.1243","article-title":"Dynamic changes in p27kip1 variant expression in activated lymphocytes.","volume":"83","author":"Yaroslavskiy","year":"2001","journal-title":"J Cell Biochem."},{"key":"2019111822051481900_B35","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/sj.onc.1203618","article-title":"Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway.","volume":"19","author":"Charrasse","year":"2000","journal-title":"Oncogene."},{"key":"2019111822051481900_B36","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0002-9440(10)62571-0","article-title":"S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase.","volume":"160","author":"Chiarle","year":"2002","journal-title":"Am J Pathol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/8\/2950\/1258736\/h82002002950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/8\/2950\/1258736\/h82002002950.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:05:30Z","timestamp":1574132730000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/8\/2950\/106451\/Expression-of-Skp2-a-p27Kip1-ubiquitin-ligase-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,15]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v100.8.2950","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10,15]]}}}